Concepedia
Statistics
Publications
12
Citations
559
H-Index
Active since
2017
Affiliations
Fox Chase Cancer Center(Current)
Lifespan
Brown University
Oncoceutics (United States)
Massachusetts General Hospital
Avital Lev is an author at Fox Chase Cancer Center specializing in oncology, molecular oncology, and medicine.
Publications per year
2017–2021
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K. Finnberg, Prashanth Gokare, Avital Lev et al. · Oncotarget · 2017 · 134 citations · Full text
Medicine, Immunology, Oncology +17
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
Jessica Wagner, C. Leah B. Kline, Marie D. Ralff et al. · Cell Cycle · 2017 · 81 citations · Full text
Medicine, Oncology, Pharmacology +9
miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells
Amriti R. Lulla, Michael Slifker, Yan Zhou et al. · Cancer Research · 2017 · 54 citations
Life Sciences, Molecular Biology, Oncology +17
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP
Avital Lev, Amriti R. Lulla, Jessica Wagner et al. · Oncotarget · 2017 · 49 citations · Full text
Medicine, Oncology, Pharmacology +13
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
Varun V. Prabhu, Amriti R. Lulla, Neel S. Madhukar et al. · PLoS ONE · 2017 · 45 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12